Canaccord Genuity Maintains Buy on Merit Medical Systems, Raises Price Target to $94

Canaccord Genuity analyst Jon Young maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and raises the price target from $85 to $94.